Guest guest Posted August 20, 2012 Report Share Posted August 20, 2012 I attach a link to their press release below: http://www.mhra.gov.uk/NewsCentre/Pressreleases/CON180627 I immediately took a look at HMPC's latest assessment documents for Echinacea angustifolia radix and Echinacea purpurea radix, dated 29/05/12 and 10/02/11 respectively. I wanted to ascertain if there was any new research that might inform our practice as herbalists in this matter. However, I couldn't find anything explicit. The MHRA have said themselves that it " is not a serious safety issue " but with the way it is being reported in the press, concerned parents are likely to ask us about it. It may be that in the context of a proper consultation with a trained herbalist, who will screen each patient for atopy, asthma, allergic tendencies etc., there is no need to change tack with regard to prescribing Echinacea to children under 12. However, if anyone knows of a reason for us as practitioners to change our approach, or knows a bit more of the background to this change in decision by MHRA and HMPC, it would be very useful to know? Many thanks, Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.